Podcasts about diagnostics

Diagnostics p. 2 - HCP 306On this podcast the team discusses more aspects of taking a healthy diagnostic within your leadership and ministry. The primary focus was approaching this with humility and prayer because "You don't know what you don't know"! Larry gets fired up when talking about prayer!You can email us at info@healthychurchpodcast.com orTo find more information about The Healthy Church Podcast go to:http://www.healthychurchpodcast.comor find us on FaceBook!

Dr. Julia Miller explains how to improve stallside diagnostic skills for equine skin conditions to prioritize differentials and guide appropriate treatment.Read the full article here: https://equimanagement.com/research-medical/diagnostics/maximizing-diagnostics-for-equine-skin-conditions/This magazine article has been transformed for your listening pleasure using AI resources.Mentioned in this episode:EquiManagement on Audio All the articles you have come to love in EquiManagement Magazine are now available in this podcast for free. Each article is released as its own separate episode to make them quick and easy to listen to. EquiManagement always has the latest insights on equine health, veterinary practice management, and veterinarian wellness.

Lumos Diagnostics CEO Doug Ward joined Steve Darling from Proactive to discuss the company's recent achievement of CLIA waiver status and the growing adoption of its FebriDx® rapid diagnostic test across the United States. Ward said FebriDx® is now being used at more than 100 healthcare locations across 18 states, including urgent care clinics, primary care practices, concierge medicine providers, and collegiate health centers. The rapid point-of-care test uses a simple fingerstick blood sample to help clinicians differentiate between bacterial infections and non-bacterial causes of illness, supporting faster treatment decisions and reducing unnecessary antibiotic prescriptions. The rollout follows the company's receipt of CLIA waiver status, which significantly expands access to the test by allowing its use in a wider range of healthcare settings. As respiratory infections remain highly seasonal, Lumos is currently focused on onboarding new customers, integrating FebriDx® into clinical workflows, and preparing healthcare providers ahead of the upcoming respiratory season. Ward noted that establishing reimbursement pathways remains a key priority. The company reported that more than 90% of submitted reimbursement claims have been paid to date, with average payments exceeding the Medicare benchmark of US$41.38 per test. Lumos is using the traditionally slower spring and summer testing period to build market awareness, support pilot programs, expand customer adoption, and further demonstrate the clinical and economic value of FebriDx® in real-world healthcare environments. Management believes the growing adoption of FebriDx® highlights increasing demand for rapid, actionable diagnostic tools that can improve patient care, support antibiotic stewardship efforts, and enhance operational efficiency at the point of care. #proactiveinvestors #lumosdiagnosticsholdings #asx #ldx #otc #ldxhf #FebriDx #PointOfCare #HealthcareInnovation #Diagnostics #PointOfCareTesting #MedicalTechnology #AntibioticStewardship #Healthcare #RapidTesting #MedTech

A 4-Step Process to Stop Stressing and Your Team Start Leading What if the exact habits that built your success are now the very thing quietly holding your business back? You hustled, you solved every problem, you held the standard — and it worked, so it became automatic. But somewhere along the way the company stopped being able to run without you, your talented team stopped stepping up, and you started wondering why working harder only makes the wheel spin faster. If any of that lands a little too close to home, this week's conversation is for you. In this episode of  A New Direction, we dig into The High-Altitude Entrepreneur with Chris Clearfield — and this episode is about you, not just the book. You'll discover why what got you here won't get you there, why all your systems still leave you trapped at the center, and the uncomfortable truth that your team won't take ownership until you stop jumping in. We even go into the brain science of it: how “predictive processing” keeps you reacting on autopilot to problems you haven't even really looked at yet — and why that's the real reason willpower never broke the cycle. Most importantly, you'll walk away with a way out. We'll unpack the shift from low-altitude founder — reactive, indispensable, exhausted — to high-altitude leader who rises above the chaos, sees the whole system, and finally lets the business grow beyond them. You'll learn how to spot the conditioned instinct that's capping your growth, how to hand your team real ownership, and why personal freedom isn't the reward you earn after success — it's the precondition that makes success possible in the first place. Join us and come ready to see your own patterns clearly, bring the questions you've been afraid to ask out loud, and bring a fellow founder who needs to hear it too. This is the conversation that helps you stop running your business from the ground — and start leading it from altitude. Chris Clearfield‘s book, “The High-Altitude Entrepreneur: A Framework for Scaling Smarter, Leading Better, and Living Freer, is a book for entrepreneurs and leaders.  And quite honestly you are going to need put aside your defensiveness, which will immediately happen when you start reading this book. Why do I say that so confidently?  Because no one wants to hear that the real problem why you as a leader are always stressed, feel like you team won’t take leadership, feel like everything falls on you, is because you are the bottleneck to your business.  But you really can’t do your out of this.  Your problem is not your people the problem is the monster you created because of the way you are wired that causes your people to not want to take action and lead. The fact is when you started your business, you pushed your way through.  You had to.  Every decision fell on you. So you put in the work, and you went into grind mode.  You lost sleep.  You pushed hard!  So now when things are not going well, or things start to go south, what do you do?  You employ your old operating system of work hard, push, and grind.  The problem.  Now you have people, and they aren’t responding. Now you are under even more stress. Your frustrated. You feel more burned out than ever.  You may even slump into depression. You think your people are lazy. They’re not the problem.  You see what got you there at the beginning was great!  But now that your business is grown, what once got you there, isn’t going to get you there now.  You don’t need to do different you need to “be” different. That is the beauty of Chris Clearfield’s book “The High-Altitude Entrepreneur”.  He has to together the High-Altitude framework that takes you step by step through a process where you can start removing yourself, so you can truly rely on others. Is it easy? Nope. Is it a quick fix? Nope. Will change your business for the better? Yep.  Will it change your life for the better? You bet! This is one of those books that if you have the guts to do it, will fundamentally change your business and you.  The book is worth every penny. Get your copy of The High-Altitude Entrepreneur by clicking here! Special Offer from Chris Clearfield If you would like to experience first hand how the process works.  Chris offers a group for free that you can watch and learn how the High-Altitude Framework works.  Just go to: Clearfieldleadership.com/elevate and sign up! Please say thank you to our sponsors!  It is their financial support that allows A New Direction to continue growing and getting great authors. “You tune in to A New Direction to grow your business and your mindset. But you can't move forward if you're worried about what's lurking in your inbox. That's where Data443 Cyren comes in. It's the industry standard for real-time email security and URL filtering. They stop phishing and malware before they strike, so you can focus on your success, not your safety. Don't let a cyberattack derail your journey. Go to Data443.com today and secure your future.“ Linda Craft Team, Realtors for more than 40 years the choice of people all over the world. They are not only experts in buying and selling real estate, they are expert negotiators that will fight for you!  But perhaps their greatest expertise is that they understand that your home is more is a place where you created some of your fondest memories. When you want a real estate professional who not only will get you the best price, but will care about your home like you would care about your home start with the Legends of Customer Service start with Linda Craft & Team.  www.LindaCraft.com ABOUT YOUR HOST Meet Jay Izso Executive Performance Coach  |  Host of A New Direction Every week on A New Direction, I sit down with CEOs, founders, and the researchers behind the science of leadership performance. The conversations go deep. We talk about the decisions that built companies, the mistakes that nearly destroyed them, and the personal breakthroughs that changed everything. But here's what most people don't know about me: the show is an extension of the work I do every day with executives behind closed doors. Who I Am I'm an Executive Performance Coach. I work with CEOs and founders of $5M-$50M companies who have hit a wall they can't explain. The marketing looks fine. The team is capable. The market is there. But the business won't move. The problem, almost every time, is the person running it. I find the personal behavioral patterns that are driving the business dysfunction. Then I help the CEO disrupt those patterns so the company can grow. That's it. No motivational platitudes. No vision boards. Diagnostics, intervention, results. Where This Comes From My approach comes from two places most coaches never set foot in. The farm. I grew up as a farmhand in Ithaca, Nebraska—population 100. I started working at nine years old. By the time I left for college, I'd spent a decade learning that you can't cheat the harvest, pain is part of the job, and the work has to get done whether you feel like it or not. I was fourteen the first time I had to castrate boars. Nobody was going to do it for me. That lesson never left: sometimes you have to do things afraid. The forensic psychology unit. In graduate school at Washington State University, I trained under Dr. Thomas Brigham—co-author of the Handbook of Applied Behavior Analysis—in a human behavior lab focused on real-world problems. I then served in a Clinical Psych II role at Eastern State Hospital in Medical Lake, Washington, a forensic setting where I conducted psychological evaluations of individuals charged with the most serious criminal offenses. Sixteen months assessing human behavior at its most extreme taught me how to cut through defenses, identify what's really driving someone's decisions, and see what they can't see in themselves.

10. juni 2026 Antibody-drug conjugates – ADC-er – er et av de heteste feltene i moderne kreftbehandling, og et område preget av høy aktivitet og store oppkjøp. Rab Diagnostics utvikler diagnostikk som kan forutsi effekten av ADC-behandling for pasienter. Anette Weyergang, forsker, gründer og CEO, er tilbake i studio for første gang siden november 2023. Vi tar en oppdatering på selskapet som springer ut av grunnforskning ved Institutt for Kreftforskning på Campus Radiumhospitalet – og snakker om teknologien, markedet og hva som står på agendaen framover.

On today's program, Michael Rogers talks with Daryn Lawson, an expert with SalesIndex and a VIP member of the Small Business Association of Michigan. His organization helps businesses optimize their revenue by applying data-driven diagnostics to the sales process using a specialized three-step methodology involving analysis, coaching, and training. "The analytics give us really a target, call it an MRI or a diagnostic like an auto mechanic would use, to really pinpoint exactly what each person in the sales role does," he says. "The analysis comes from the kind of an assessment that gives us the behavioral psychology and then tactical sales skills." Lawson emphasizes that long-term sales success is built on authentic relationships, discipline, and providing meaningful value to customers. The Small Business Association of Michigan is the only statewide and state-based association that focuses solely on serving the needs of Michigan's small business community. We have been successfully serving small businesses like yours in all 83 counties of Michigan since 1969. We're located in Lansing, just one block from the Capitol. Our mission is to help Michigan small businesses succeed by promoting entrepreneurship, leveraging buying power and engaging in political advocacy. When small businesses band together through the Small Business Association of Michigan, they achieve more than they could on their own.  Our 32,000 members are as diverse as Michigan's economy. From accountants to appliance stores, manufacturers to medical, and restaurants to retailers, what unites the SBAM membership is the spirit of entrepreneurship…a spirit that drove you to start and continue to operate your own business because you believe you can do something better than anyone else is doing it! (music licensed from www.jukedeck.com)

Developing a cancer drug is one of the most expensive, slow, and failure-prone processes in modern science. PharosAI is trying to change that – by building multimodal, AI-ready datasets from donated cancer tissue samples and making them available to researchers, biotech companies, and clinicians.In this episode, Technical Director Adrian La Porta speaks with PharosAI's Dr Lucie Burgess (COO) and Dr Emma Colliver (Research Fellow) about what it takes to curate cancer data at scale, why federated learning matters for patient privacy, where AI is already transforming diagnostics, and what synthetic patients could mean for clinical trials.Whether you work in life sciences, pharma manufacturing, digital health, or clinical data governance, understanding how AI is reshaping the drug discovery pipeline has direct implications for how and when new facilities will need to be built. This one is worth your time.Topics covered:00:00 Introduction00:01 What is PharosAI?00:06 Why AI can fundamentally change cancer care00:08 The venture behind the mission00:12 Lowering the barrier for UK biotech00:16 Are we at an inflection point?00:20 AI in diagnostics – what's already working00:24 Misconceptions about AI in biotech00:30 Data – acquiring, cleaning, and structuring00:34 Patient privacy, consent, and NHS data00:37 What cancer care could look like in 10 years00:40 Why this work matters personallySend us Fan MailTo learn more about Bryden Wood's Design to Value philosophy, visit www.brydenwood.com. You can also follow Bryden Wood on LinkedIn.

Welcome to another episode of The Brand Called You featuring Shubham Mishra, Founder & CEO, Energy AI Labs.In this enlightening conversation with Ashutosh Garg, Shubham shares his entrepreneurial journey—from building E-bikes to pioneering cutting-edge battery diagnostics in India. Discover the challenges of Deep Tech innovation, the evolution of EV Doctor, and the vision behind creating a universal Energy OS for homes and businesses.Shubham also delves into battery myths, the impact of AI and field data on diagnostics, and what the future holds for Energy Super Intelligence.Whether you are passionate about EVs, AI, or the sustainable energy revolution, this episode delivers practical wisdom, fascinating stories, and a glimpse into the future of how the world will produce, consume, and value energy.

Подкаст RadioDotNet выпуск №137 от 8 июня 2026 года В этом эпизоде вы можете услышать историю про наш совместный митап от международного разработчика ПО Altenar. Сайт подкаста: radio.dotnet.ru Boosty (₽): boosty.to/RadioDotNet Темы: [00:01:30] — Improving C# Memory Safety devblogs.microsoft.com/dotnet/improving-csharp-memory-safety [00:22:05] — Combining API versioning with OpenAPI devblogs.microsoft.com/dotnet/api-versioning-in-dotnet-10-app... [00:45:05] — System.Diagnostics.Metrics APIs andrewlock.net/series/system-diagnostics-metrics-apis [01:03:00] — Propagating OpenTelemetry context in .NET meziantou.net/propagating-opentelemetry-context-in-d... [01:25:55] — Vertical Slice Architecture vs Clean Architecture dev.to/gramli/net-vertical-slice-architecture... [01:37:40] — Кратко о разном xaml.dev/post/automatically-getting-api-differe... Фоновая музыка: Максим Аршинов «Pensive yeti.0.1»

We are in the third week of our four-part series on the 5th-largest killer in America.  This week, we talk about the diagnostics that can help prevent Chronic Lower Respiratory Disease and the tests that can help provide a roadmap to actually reverse it.  In this episode, you'll learn:—How Asthma is the majority of CLRD cases, while COPD is the number one category of CLRD deaths.—Why the Spirometry Lung Function Test is the most important tool to diagnose the Lungs.  And why Dr. Prather does not charge for follow-up Spirometry tests for those with severe Lung problems. —What factors Dr. Prather looks for to determine when  a Chest X-Ray is needed or when CT imaging is required for a patient.  And the common calcification Dr. Prather sees on Chest X-Rays due to Indianapolis being the "Histoplasmosis Capitol of America". —The importance of Vitamin D testing for respiratory health and the role it played during COVID.  And why Dr. Prather believes CLRD could be lowered by 85% if people just keep their Vitamin D levels in proper range.—The importance of Vitamin A as the recommended treatment for Measles.  And the history behind Cod Liver Oil as a great supplement for kids.—The importance of a Pulse Oximeter to check Blood Oxygen levels as a standard screening for all patients. —How Hair Analysis has been an important key to the health of so many patients, such as identifying toxic heavy metals like Cadmium which cause long-term damage to the Lungs. —Why Dr. Prather believes Sputum Cultures are under-utilized. —How a Stool Kit plays an important role for Lung health by identifying leaky gut issues that lead to Food Allergies.  Plus, how Parasites are a big cause of severe childhood Asthma and adult-onset Asthma.—Why too LOW levels of Hydrochloric Acid "almost always kicks off allergies" and is the reason for GERD and heartburn.  And why Proton Pump Inhibitors like Pepcid actually make the problem worse by lowering the Hydrochloric Acid in your stomach even more.http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

The following article of the Health industry is: 'AI in Diagnostics: When Speed Outruns Trust' by Héctor Barillas, General Manager, Wiener Lab. 

Send us Fan MailOver the last several years, artificial intelligence has transformed from a speculative concept in healthcare into one of the most heavily funded movements in pharmaceutical and biotech history.But in 2026, the conversation is changing. The question is no longer whether AI can generate molecules, analyze pathology slides, or identify patterns in clinical data. The real question is: which of these technologies can survive the complexity of biology, regulatory scrutiny, clinical validation, and real-world deployment?Today we're joined once again by returning guest Bill Taranto, President and Founding Partner of the Merck Global Health Innovation Fund ( https://www.merckghifund.com/ ), alongside Managing Director, Dr. David Rubin, who brings a deep scientific background spanning molecular biology, oncology, precision medicine, and digital health investing.Together, Bill and David sit at a unique intersection of pharma strategy, venture investing, translational science, and clinical deployment. Through investments across AI-driven drug discovery, precision medicine, diagnostics, and digital health - including early involvement with companies like PathAI - they've had a front-row seat to what's actually working in AI-enabled healthcare…and what still breaks down when these systems encounter real-world medicine.Today we'll explore where AI is genuinely creating value across the pharmaceutical stack, why some approaches are beginning to achieve meaningful validation, what investors and pharma companies are now demanding beyond hype, and how entirely new experimental models - from organoids to AI-native biology platforms - may reshape the future of drug development.#AI #ArtificialIntelligence #DrugDiscovery #Biotech #Pharma #HealthcareAI #PrecisionMedicine #DigitalHealth #Oncology #PathAI #Roche #Biology #MachineLearning #BiotechInvesting #VentureCapital #Merck #DigitalPathology #ClinicalTrials #FutureOfMedicine #LifeSciences #AIHealthcare #MedicalInnovation #Biotechnology #CancerResearch #PrecisionOncology #Bioinformatics #HealthcareInnovation #Pharmaceuticals #MedTech #ProgressPotentialPossibilitiesSupport the show

Dr. Julie Chen, Chief Medical Officer at Radence, outlines the use of genomic precision medicine and advanced biomarkers and imaging technology for early detection and diagnosis of disease, with a focus on extending the health span, not just the lifespan, of their clients.  This comprehensive membership-based model aggregates members' health data to create a 360° view of their health risks. AI is a critical tool for identifying trends in longitudinal data, enabling more accurate and personalized health monitoring for both those who are healthy and those recovering from an existing condition. Julie explains, "Our model is a membership-based model primarily because a lot of the leading-edge technology is not insurance-covered. And so we're able to then utilize what is necessary for the diagnosis and the management, and actionable steps for the members, without having to worry about what insurance will or will not cover." "Our members come through, and we actually aggregate all of their outside medical records and data because we want to see what their baseline health has been up to the point that they join us as a member. And then at that point, we actually get from the cellular level all the way up to the organ level and functionality level, we start to aggregate information about their genomics, so the blueprint of who they are health-wise."   "The key focus here is really looking at the concept that longevity is a larger picture phrase that has been in this industry, used across the board for a lot of different things. That could encompass biohacking, to true evidence-based genomic precision medicine, to just trends of what people are using. So I think it's really important for your listeners to understand that longevity is theoretically in the category of what we're doing in that space, but the very important point is to really look at the space, as there are a lot of things on the market now."   #Radence #GenomicMedicine #PrecisionMedicine #EarlyDetection #HealthSpan #Longevity #AIinHealthcare #PreventiveCare  Radence.com Listen to the podcast here

Dr. Julie Chen, Chief Medical Officer at Radence, outlines the use of genomic precision medicine and advanced biomarkers and imaging technology for early detection and diagnosis of disease, with a focus on extending the health span, not just the lifespan, of their clients.  This comprehensive membership-based model aggregates members' health data to create a 360° view of their health risks. AI is a critical tool for identifying trends in longitudinal data, enabling more accurate and personalized health monitoring for both those who are healthy and those recovering from an existing condition. Julie explains, "Our model is a membership-based model primarily because a lot of the leading-edge technology is not insurance-covered. And so we're able to then utilize what is necessary for the diagnosis and the management, and actionable steps for the members, without having to worry about what insurance will or will not cover." "Our members come through, and we actually aggregate all of their outside medical records and data because we want to see what their baseline health has been up to the point that they join us as a member. And then at that point, we actually get from the cellular level all the way up to the organ level and functionality level, we start to aggregate information about their genomics, so the blueprint of who they are health-wise."   "The key focus here is really looking at the concept that longevity is a larger picture phrase that has been in this industry, used across the board for a lot of different things. That could encompass biohacking, to true evidence-based genomic precision medicine, to just trends of what people are using. So I think it's really important for your listeners to understand that longevity is theoretically in the category of what we're doing in that space, but the very important point is to really look at the space, as there are a lot of things on the market now."   #Radence #GenomicMedicine #PrecisionMedicine #EarlyDetection #HealthSpan #Longevity #AIinHealthcare #PreventiveCare  Radence.com Download the transcript here

You Don’t Need a Business Transformation…you need a YOU Transformation Ever feel like you're doing all the “right” things—reading the self-help books, checking off your goals, grinding every day—but inside, you're still wrestling with the exact same anxieties? You aren’t broken; you’ve just hit the ceiling of what your current self can handle. Real, lasting change requires more than just adding new habits to your daily routine; it demands a total identity transformation. If you are ready to stop merely managing your symptoms and start evolving who you are at your core, it is time for a radical internal upgrade. Today on A New Direction, Coach Jay dives deep into this psychological frontier with cutting-edge mindset expert and best-selling author, Dr. Ryan Gottfredson. We are breaking open his latest, game-changing book, Becoming Better: The Ground Breaking Science of Persona Transformation. Dr. Gottfredson bypasses the usual self-help clichés to deliver the actual, hard science behind vertical development. He will show us how to achieve a deep mental transformation that rewires our internal operating systems for unprecedented success and peace. In this powerful conversation, you will discover why traditional willpower consistently fails and how your hidden mindsets are secretly sabotaging your growth. Dr. Gottfredson will reveal the neurological and psychological blueprints necessary to shed your defensive armor, heal old wounds, and accelerate your personal transformation. This isn’t a superficial conversation about doing more; it is an exploration of how to fundamentally alter how you see yourself and the world from the inside out. Do not miss this chance to experience a life-altering transformation in real-time. Join us right here on A New Direction with Coach Jay to catch every insight, absorb the science, and discover the keys to unlocking your next level. Your old self has taken you as far as it can—it is time to step into the ultimate transformation and meet the person you were actually meant to become. A FREE Transformational Offer!  If you go to RyanGottfredson.com and you click on any of the assessments and tell Ryan you heard him on my show A New Direction with Coach Jay he will give you a FREE 30 minutes call to go over your assessment! Just click here for the assessments. Ryan Gottfredson’s Book, “Becoming Better: The Groundbreaking Science of Personal Transformation” is a life changing book that will be transformational for your business.  You may be asking how can that be?  Because the fact is your business success is limited by your personal success in life.  And when you are broken (which we all are) we are never going to be as successful in life and business until we start our journey of healing from the inside out. Dr Gottfredson likes to use the analogy of our brain and reactions, and mindsets and thinking as an operating system.  That operating system has coding from birth to now.  So, anything that we react to our coding kicks in and we respond in a way that can damage our success.  So, the fact is our operating system really needs to be recoded, the problem is we don’t want to do the hard work to do it. But here is the irony.  When we have problems in life and business what do we typically do?  We try to find ways we can “do” our way out of something.  We may go to a conference to go new ways of “doing” things.  That all sounds great but let’s take the analogy one step further.  Think of it this way.  If you download another app on your phone to help you “do” something, but your operating system coding (IOS) is screwed up, and is a mess, how effective is that app… it’s not. And no transformation. That’s the point of Becoming Better.  Until you change the coding from the bad coding in your past all the “do this” and “do that” are nothing more than great apps on a horribly written operating system. And your business and life transformation is at a stand still. The brilliance of the book is that not only does Dr. Gottfredson address these issues he gives you the science behind them and offers the small building blocks and steps to start erasing the bad code in your operating system and writing new code.  But it is not easy.  And I am speaking from my own experience here.  When you realize just how much trauma in your past (that you will deny, like I did) and how it has affected your coding, you will see how much success you can achieve. Please get a copy of this book Becoming Better and do the work! We really would like to ask you to thank our sponsors.  Their financial support of A New Direction is so critical to helping us provide quality guests, books, and great sounding show. “You tune in to A New Direction to grow your business and your mindset. But you can't move forward if you're worried about what's lurking in your inbox. That's where Data443 Cyren comes in. It's the industry standard for real-time email security and URL filtering. They stop phishing and malware before they strike, so you can focus on your success, not your safety. Don't let a cyberattack derail your journey. Go to Data443.com today and secure your future.“ Linda Craft Team, Realtors they literally are a locally owned independent real estate company,  that serves the world. How can a small company serve the world? They have created relationships with the best real estate experts in the world to help you regardless of where you live get the best person possible. And because they are independent of any national brand, they have relationships with other professionals from all the companies, not just the ones that are part of a national branded network. For more than 39 years they continue to build relationships because that is how Linda started the business and continues to do so today.  Head on over to www.LindaCraft.com Hey…do me a favor and please tell your friends to subscribe to A New Direction on their favorite podcast platform and give us a 5 star rating we are so grateful when you do! ABOUT YOUR HOST Meet Jay Izso Executive Performance Coach  |  Host of A New Direction Every week on A New Direction, I sit down with CEOs, founders, and the researchers behind the science of leadership performance. The conversations go deep. We talk about the decisions that built companies, the mistakes that nearly destroyed them, and the personal breakthroughs that changed everything. But here's what most people don't know about me: the show is an extension of the work I do every day with executives behind closed doors. Who I Am I'm an Executive Performance Coach. I work with CEOs and founders of $5M-$50M companies who have hit a wall they can't explain. The marketing looks fine. The team is capable. The market is there. But the business won't move. The problem, almost every time, is the person running it. I find the personal behavioral patterns that are driving the business dysfunction. Then I help the CEO disrupt those patterns so the company can grow. That's it. No motivational platitudes. No vision boards. Diagnostics, intervention, results. Where This Comes From My approach comes from two places most coaches never set foot in. The farm. I grew up as a farmhand in Ithaca, Nebraska—population 100. I started working at nine years old. By the time I left for college, I'd spent a decade learning that you can't cheat the harvest, pain is part of the job, and the work has to get done whether you feel like it or not. I was fourteen the first time I had to castrate boars. Nobody was going to do it for me. That lesson never left: sometimes you have to do things afraid. The forensic psychology unit. In graduate school at Washington State University, I trained under Dr. Thomas Brigham—co-author of the Handbook of Applied Behavior Analysis—in a human behavior lab focused on real-world problems. I then served in a Clinical Psych II role at Eastern State Hospital in Medical Lake, Washington, a forensic setting where I conducted psychological evaluations of individuals charged with the most serious criminal offenses. Sixteen months assessing human behavior at its most extreme taught me how to cut through defenses, identify what's really driving someone's decisions, and see what they can't see in themselves.

On this podcast, Larry, Drew and Heidi start the conversation about being able to diagnose different issues in the church. The first place to consider is our own hearts and what may be keeping our leadership from being as effective. Addressing personal sin and right timing are the focus today and the wrap up is that we must always realize that PEOPLE ARE MORE IMPORTANT THAN YOUR PROJECT. You can email us at info@healthychurchpodcast.com orTo find more information about The Healthy Church Podcast go to:http://www.healthychurchpodcast.comor find us on FaceBook!

Dr. Yana Aznavour, CEO and Founder of Endometrics, discusses the significant diagnostic delay women face with endometriosis due to non-specific symptoms and the current reliance on invasive surgery for a definitive diagnosis. The company has developed a non-invasive at-home diagnostic test that uses menstrual blood to analyze a five-gene biomarker signature with high accuracy.  This objective, molecular-based test shortens the time to the correct treatment and changes the dynamic of the patient-doctor conversation. Yana explains, "We are developing non-invasive diagnostic tests, and we are primarily addressing the huge diagnostic delay that our patients, women, face, unfortunately. This happens because there are tons of non-specific symptoms and inconclusive imaging findings, and women face unnecessary appointments and procedures before reaching the point of definitive diagnosis. We are working rigorously towards bringing non-invasive, highly reliable diagnostic tests to help women get clarity and answers behind their symptoms way earlier in the journey."   "Menstrual pain and pain in general that women try to express and define at physician's appointments, it's being dismissed because they try to explain that, but in many cases, they cannot find exactly where it hurts, especially in endometriosis. Due to this, unfortunately, at the primary care level and the non-OB/GYN level, they're being dismissed and repeatedly misdiagnosed for years. The key reason is the non-specific symptoms because symptoms like pelvic pain and pain with urination overlap with the list of diagnoses. Currently, the definitive diagnosis for endometriosis is achieved through surgery. Nobody would do surgery after the first appointment. So, endometriosis becomes a diagnosis of exclusion, unfortunately, and it takes years before patients receive the final diagnosis." #Endometrics #Endometriosis, #WomensHealth, #Biomarkers, #Diagnostics, #FemTech #Gynecology #PrecisionMedicine endometrics.us Download the transcript here

Dr. Yana Aznavour, CEO and Founder of Endometrics, discusses the significant diagnostic delay women face with endometriosis due to non-specific symptoms and the current reliance on invasive surgery for a definitive diagnosis. The company has developed a non-invasive at-home diagnostic test that uses menstrual blood to analyze a five-gene biomarker signature with high accuracy.  This objective, molecular-based test shortens the time to the correct treatment and changes the dynamic of the patient-doctor conversation. Yana explains, "We are developing non-invasive diagnostic tests, and we are primarily addressing the huge diagnostic delay that our patients, women, face, unfortunately. This happens because there are tons of non-specific symptoms and inconclusive imaging findings, and women face unnecessary appointments and procedures before reaching the point of definitive diagnosis. We are working rigorously towards bringing non-invasive, highly reliable diagnostic tests to help women get clarity and answers behind their symptoms way earlier in the journey."   "Menstrual pain and pain in general that women try to express and define at physician's appointments, it's being dismissed because they try to explain that, but in many cases, they cannot find exactly where it hurts, especially in endometriosis. Due to this, unfortunately, at the primary care level and the non-OB/GYN level, they're being dismissed and repeatedly misdiagnosed for years. The key reason is the non-specific symptoms because symptoms like pelvic pain and pain with urination overlap with the list of diagnoses. Currently, the definitive diagnosis for endometriosis is achieved through surgery. Nobody would do surgery after the first appointment. So, endometriosis becomes a diagnosis of exclusion, unfortunately, and it takes years before patients receive the final diagnosis." #Endometrics #Endometriosis, #WomensHealth, #Biomarkers, #Diagnostics, #FemTech #Gynecology #PrecisionMedicine endometrics.us Listen to the podcast here

Send us Fan MailWhat if the next pandemic could be identified, diagnosed, and targeted with programmable CRISPR therapeutics before it spreads globally? That's exactly what Seek Labs is trying to build.Jared Bauer is CEO of Seek Labs ( https://seeklabs.com/ ), a clinical-stage TechBio company developing an integrated platform that combines AI-driven genomic intelligence, rapid field diagnostics, and CRISPR-based therapeutics designed to identify and potentially counter emerging pathogens faster than ever before.In a world where outbreaks can spread globally before traditional systems even identify the threat - as we saw with COVID and more recently with delayed hantavirus confirmation cases - Seek Labs is asking a bold question: what if diagnostics and therapeutics could be programmed and deployed at the speed of software?Jared is also Chairman of BioHive Utah ( https://www.biohive.com/ ), one of the fastest-growing life science ecosystems in the United States, and has spent his career at the intersection of biotech innovation, AI, diagnostics, and public health preparedness.We discuss AI-driven drug discovery, CRISPR therapeutics, programmable outbreak response, biodefense infrastructure, and what the next generation of pandemic preparedness may actually look like.#SeekLabs #JaredBauer #CRISPR #AI #Biotech #PandemicPreparedness #BioDefense #Diagnostics #Therapeutics #GeneEditing #SyntheticBiology #InfectiousDisease #FutureOfMedicine #HealthcareInnovation #PrecisionMedicine #Biotechnology #BARDA #ARPAH #DiseaseSurveillance #TechBio #OutbreakResponse #Biosecurity #AIinHealthcare #MedicalInnovation #PodcastSupport the show

What if the biggest barrier to better healthcare outcomes is… the blood draw itself? In this episode, Web Golinkin, President at Babson Diagnostics, discusses how his company is reinventing blood testing with a patient-friendly, fingertip-based system. He explains why traditional venipuncture drives anxiety and non-adherence, and how BetterWay improves both experience and outcomes. He also shares how automation and simplified workflows reduce operational burden and expand access points for care. Finally, he explores why patient experience is becoming the key competitive differentiator in ambulatory healthcare. Tune in to learn how rethinking a decades-old process could unlock better care, better business, and better patient engagement. Resources: Connect with and follow Web Golinkin on LinkedIn, visit his website, or reach out via email! Follow Babson Diagnostics on LinkedIn and explore their website! Learn more about BetterWay here!

Mike talks with two game designers, a nuclear physicist and sound artist about how the iconic videogame became what it is today: something that runs on every piece of technology (and increasingly: biology) known to man–Become a member at https://neverpo.st– Call us at 651 615 5007 to leave a voicemail Drop us a voice memo via airtable Or email us at theneverpost at gmail dot com –Everything Plays Doom Xaser Acheron on Doomwiki and Github Bijan Stephen's Website and Bsky John Matter's Website and Bsky Matthew Gantt on Instagram and Diagnostics, his record on OMR  Doom Guy: Life in First Person, by John Romero Master of Doom: How Two Guys Created an Empire and Transformed Pop Culture, by David Kushner Next Generation Magazine, 30 Jun 1997 Compute! Magazine Issue 163 Computer Gaming World Issue 116Computer Gaming World Issue 116 Doom Editing Utilities, Doomwiki Other uses for DOOM engine, Usenetarchives Zfootball, Doomhockey, Hellshots, Gallery Experience, MyHouse.wad –Never Post's producers are Audrey Evans, Georgia Hampton and The Mysterious Dr. Firstname Lastname. Our senior producer is Hans Buetow. Our executive producer is Jason Oberholtzer. The show's host is Mike Rugnetta.I got a tattoo of God. You can't see itbut it's everywhere. If I seem out of it,do the math. I was put on earth.And then you were, making up your feetas you went along. New thinspo clanks the spank bank. New emoticon makes a Holocene. Excerpt of Money Bin by Michael RobbinsNever Post is a production of Charts & Leisure and is distributed by Radiotopia

Forget McDonald’s and Chick-Fi-A Non-Food Franchising May be a Better Bet When most people think of starting a business, their minds immediately go to fast food. We've been conditioned to associate “franchising” with burgers, fries, and massive overhead. But in his game-changing book, “Non-food franchising: The Better Path to Business Ownership,” Jon Ostenson explains why you might want to leave the grease traps behind. This isn’t just about picking a different industry; it's about a fundamental shift in how you build wealth. Non-food franchising offers a gateway to high-margin, essential-service businesses that provide the stability the food industry often lacks. There is a profound emotional cost to staying in a corporate job that no longer serves you. We all crave a sense of agency over our own lives, and non-food franchising is designed to provide exactly that. Jon explores how these businesses—ranging from home services to specialized health care—allow “corporate refugees” to stop trading hours for dollars. It's about building a legacy that supports your family and your freedom, using a proven system that doesn’t require you to be the one performing the labor. If you've ever felt like your potential is being capped by a ceiling someone else built, this conversation will be your sledgehammer. During our live deep dive, we'll look at why the most successful investors are flocking to non-food franchising. These businesses are often “recession-resistant” because they provide services people need rather than just things they want. We will break down the semi-absentee model, showing you how to scale a portfolio of businesses while keeping your day job or enjoying your retirement. By focusing on non-food franchising, you minimize the complexity of high-turnover staff and perishable inventory, focusing instead on the “boring” businesses that produce exciting, consistent cash flow. You cannot afford to miss this high-impact session on A New Direction with Coach Jay. Join us live this Wednesday, May 27th at 5pm Eastern as we interview Jon Ostenson and pull back the curtain on the lucrative world of non-food franchising. Whether you're looking to diversify your investments or completely pivot your career, this episode will give you the roadmap to move forward with confidence. Tune in and discover why your next big move doesn’t have to involve a drive-thru window. Jon Ostenson‘s book, “Non-Food Franchising: The Better Path to Business Ownership” is one of those powerful books in a short read.  The fact is I learned more about non-food franchising in this 75-page book than I had learned in my lifetime.  In fact, the book was so good, it has got me thinking about investing in to a non-food franchising opportunity. What I found so great about the book is that it is an honest, simple look at why non-food franchising is such a great opportunity.  He looks at the pros and cons of comparing to food franchises.  He also compares to the challenges of starting your own business or perhaps purchasing someone else’s business. Now don’t think that what Jon Ostenson is saying is all butterflies and roses when it comes to franchising.  Because he is not.  He points out there is a risk.  And he also points out something else.  It is not for everyone.  The fact is you could be “TOO entrepreneurial” for a non-food franchise, because you like to tweak and do things your own way.  That’s where you need to put your ego aside, accepting some humility comes in. The book talks about the subject of how to get money, different avenues to get started, and a step-by-step process he uses.  He also discusses the documents that are reviewed and specific areas to pay very close attention to.  Glad I read it twice! To get your copy of “Non-Food Franchising” click here. Please thank our sponsors of A New Direction by going to their social media pages liking them and following them. “You tune in to A New Direction to grow your business and your mindset. But you can't move forward if you're worried about what's lurking in your inbox. That's where Data443 Cyren comes in. It's the industry standard for real-time email security and URL filtering. They stop phishing and malware before they strike, so you can focus on your success, not your safety. Don't let a cyberattack derail your journey. Go to Data443.com today and secure your future.“ Linda Craft Team, Realtors for more than 40 years they have been helping people all over the world take the stress out of real estate.  And they would love to help you! When Linda started the business she built it by reputation and one relationship at a time and that is a foundation that continues to be built today. They truly understand that when you think about your home it is more than bricks and mortar, you made memories there and you want someone who cares about those as much as possible as you do. When you are ready to sell or buy your home, start with the relationship builders and home transition experts.  Start with Linda Craft Team, Realtors… www.LindaCraft.com ABOUT YOUR HOST Meet Jay Izso Executive Performance Coach  |  Host of A New Direction Every week on A New Direction, I sit down with CEOs, founders, and the researchers behind the science of leadership performance. The conversations go deep. We talk about the decisions that built companies, the mistakes that nearly destroyed them, and the personal breakthroughs that changed everything. But here’s what most people don’t know about me: the show is an extension of the work I do every day with executives behind closed doors. Who I Am I’m an Executive Performance Coach. I work with CEOs and founders of $5M-$50M companies who have hit a wall they can’t explain. The marketing looks fine. The team is capable. The market is there. But the business won’t move. The problem, almost every time, is the person running it. I find the personal behavioral patterns that are driving the business dysfunction. Then I help the CEO disrupt those patterns so the company can grow. That’s it. No motivational platitudes. No vision boards. Diagnostics, intervention, results. Where This Comes From My approach comes from two places most coaches never set foot in. The farm. I grew up as a farmhand in Ithaca, Nebraska—population 100. I started working at nine years old. By the time I left for college, I’d spent a decade learning that you can’t cheat the harvest, pain is part of the job, and the work has to get done whether you feel like it or not. I was fourteen the first time I had to castrate boars. Nobody was going to do it for me. That lesson never left: sometimes you have to do things afraid. The forensic psychology unit. In graduate school at Washington State University, I trained under Dr. Thomas Brigham—co-author of the Handbook of Applied Behavior Analysis—in a human behavior lab focused on real-world problems. I then served in a Clinical Psych II role at Eastern State Hospital in Medical Lake, Washington, a forensic setting where I conducted psychological evaluations of individuals charged with the most serious criminal offenses. Sixteen months assessing human behavior at its most extreme taught me how to cut through defenses, identify what’s really driving someone’s decisions, and see what they can’t see in themselves.

Merci à notre commanditaire ProCafetière :  https://tinyurl.com/procafetiere-jerr Pour obtenir le Café Whats Up : https://procafetiere.ca/collections/cafe-vrac/products/espresso-whats-up-cafe-vrac Utilise le code JERR20 pour 20% de rabais sur le sac Whats Up ;) Diagnostics erronés, mauvais traitements, soins négligés… Elle a même dû, par elle-même, envoyer ses échantillons à l'Université Harvard et au CHUM à Montréal pour enfin obtenir le bon traitement et faire entendre raison à son oncologue. Voici Chanel Maisonneuve, l'une des femmes les plus courageuses que j'ai eu la chance de rencontrer. Et bien qu'elle se batte encore aujourd'hui contre un cancer (récidive), elle poursuit le gouvernement afin de le forcer à prendre ses responsabilités, pour que plus jamais un Québécois n'ait à vivre ce qu'elle a vécu. Un podcast de 2 h 20 à la fois inspirant, émouvant… et franchement frustrant. Merci, Chanel ! Enregistré le 30 mars 2026. Liens pour suivre Chanel : https://www.facebook.com/people/Chanel-Maisonneuve/821870429/ Lien pour faire un don : https://www.gofundme.com/f/aidezmoi-apres-2-cancers-du-sein?attribution_id=sl:6b87fe0f-207c-4a36-95e7-72381c14ca15 Pour devenir membre et supporter le Whats Up Podcast : https://www.patreon.com/whatsuppodcast  Merci les patreon !!  Site web officiel : https://jerrallain.com/ Pour suivre Jerr sur Instagram :  https://www.instagram.com/jerr_allain/  Pour suivre Jerr sur facebook : https://www.facebook.com/JerrAllainofficiel Contact : jerr.production@gmail.com  Pour vous abonner à mon Infolettre :  http://eepurl.com/hvpnhj

Only one in three eligible lung cancer patients receives the targeted therapy they should get.That is not a failure of science.It is a failure of delivery.After more than two decades of precision oncology, biopharma has never had better tools: cell and gene therapy, in vivo CAR-T, antibody-drug conjugates, AI-enabled diagnostics, organoids, multi-omics, and global clinical data.Yet too many breakthroughs still fail to reach the bedside.Patients fall through fragmented systems.Data does not move cleanly.Community oncologists are overloaded.Tests are missed, delayed, or misread.Promising assets die in quarterly portfolio reviews.And healthcare systems built for pills, tablets, and chronic disease management are now being asked to deliver personalized medicine at scale.In this SPARK20 highlight episode, Alasdair Milton, PhD, Principal at KPMG and leader of the firm's Precision & Advanced Therapies practice, explains why the future of biopharma will not be decided by science alone.It will be decided by translation.From lab bench to boardroom.From data to decisions.From treatment to prevention.Alasdair brings more than 20 years of experience across life sciences strategy, commercial due diligence, precision medicine, advanced therapies, cell and gene therapy, biopharma M&A, diagnostics, and global healthcare transformation.This conversation moves from the precision medicine delivery crisis to China's biotech acceleration, from AI and organoids to trapped pharma assets, from lifelong wellness to the one skill every future biotech leader needs:The ability to translate complex science into business strategy, capital allocation, and patient impact.What You'll Learn in 22 MinutesWhy only one third of eligible lung cancer patients receive targeted therapy(00:01:53)And why precision medicine still breaks in everyday clinical practice.Why science keeps compounding even when systems fail(00:04:33)Including in vivo CAR-T, functional cures, gene therapy, and antibody-drug conjugates.Why innovation does not move in a straight line(00:05:20)How technologies can look dead for years before suddenly changing the market.Why China's biotech speed matters(00:07:36)How AI, organoids, scale, and execution are changing the global innovation map.Why great science dies inside Big Pharma(00:09:20)And how deprioritized assets can become billion-dollar companies when externalized properly.Why the industry must move from sickness to lifelong wellness(00:10:03)Alasdair's vision for a more proactive, preventive, data-driven healthcare system.Why pharma needs better ways to rescue shelved assets(00:13:06)Including examples such as SpringWorks, Cerevel, and new models for unlocking trapped value.How a 400-person Scottish island shaped Alasdair's worldview(00:15:07)The personal story behind his resilience, discipline, and leadership style.Why careers and companies are never linear(00:17:19)What Alasdair learned after moving to Boston and losing his role within weeks.Why the future belongs to translators(00:20:06)The most valuable skill in biotech: explaining complex science to business leaders, investors, and boards.How to connect with Alasdair Milton and the KPMG Precision & Advanced Therapies team(00:21:47)Quotes to Carry With You

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden speaks with Nicole Bell and Jennifer Miller from Galaxy Diagnostics about the challenges and advancements in diagnosing and treating tick-borne illnesses, particularly Lyme disease. They discuss the personal journey that led Nicole to become the CEO of Galaxy Diagnostics, the complexities of the immune response to Lyme, and the innovative diagnostic approaches being developed to improve patient outcomes. The conversation also touches on the implications of co-infections and the future of research in this critical area of health.   For Audience Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now   Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!      Takeaways ·       Nicole Bell's personal experience with tick-borne illness led her to Galaxy Diagnostics. ·       Lyme disease can be misdiagnosed, leading to severe consequences. ·       The immune response to Lyme is complex and can lead to chronic inflammation. ·       Genetic predispositions can affect how individuals respond to tick-borne pathogens. ·       Innovative diagnostic methods are being developed to improve detection of Lyme and co-infections. ·       Urine samples can be effective for diagnosing Lyme disease. ·       Co-infections like Bartonella can complicate treatment and diagnosis. ·       Early diagnosis is crucial for effective treatment of tick-borne illnesses. ·       Research is ongoing to better understand the relationship between tick-borne pathogens and mental health. ·       Galaxy Diagnostics aims to change the standard of care for tick-borne illnesses.     Chapters 00:00 Introduction to Tick-Borne Illnesses 05:04 The Journey of Diagnosis and Treatment 09:50 Understanding Lyme Disease and Its Challenges 14:53 The Immune Response and Genetic Factors 19:54 Innovative Diagnostic Approaches 24:53 Co-Infections and Their Implications 29:55 The Future of Tick-Borne Pathogen Research   To learn more about Nicole Bell/Galaxy Diagnostics:Email: nicole.bell@galaxydx.com Website: https://www.galaxydx.com/   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw       Gladden Longevity Podcast Disclosures Production & Independence The Gladden Longevity Podcast and Age Hackers are produced by Gladden Longevity Podcast, which operates independently from Dr. Jeffrey Gladden's clinical practice and research at Gladden Longevity in Irving, Texas. Dr. Gladden may serve as a founder, advisor, or investor in select health, wellness, or longevity-related ventures. These may occasionally be referenced in podcast discussions when relevant to educational topics. Any such mentions are for informational purposes only and do not constitute endorsements. Medical Disclaimer The Gladden Longevity Podcast is intended for educational and informational purposes only. It does not constitute the practice of medicine, nursing, or other professional healthcare services — including the giving of medical advice — and no doctor–patient relationship is formed through this podcast or its associated content. The information shared on this podcast, including opinions, research discussions, and referenced materials, is not intended to replace or serve as a substitute for professional medical advice, diagnosis, or treatment. Listeners should not disregard or delay seeking medical advice for any condition they may have. Always seek the guidance of a qualified healthcare professional regarding any questions or concerns about your health, medical conditions, or treatment options. Use of information from this podcast and any linked materials is at the listener's own risk. Podcast Guest Disclosures Guests on the Gladden Longevity Podcast may hold financial interests, advisory roles, or ownership stakes in companies, products, or services discussed during their appearance. The views expressed by guests are their own and do not necessarily reflect the opinions or positions of Gladden Longevity, Dr. Jeffrey Gladden, or the production team. Sponsorships & Affiliate Disclosures To support the creation of high-quality educational content, the Gladden Longevity Podcast may include paid sponsorships or affiliate partnerships. Any such partnerships will be clearly identified during episodes or noted in the accompanying show notes. We may receive compensation through affiliate links or sponsorship agreements when products or services are mentioned on the show. However, these partnerships do not influence the opinions, recommendations, or clinical integrity of the information presented. Additional Note on Content Integrity All content is carefully curated to align with our mission of promoting science-based, ethical, and responsible approaches to health, wellness, and longevity. We strive to maintain the highest standards of transparency and educational value in all our communications.

In this episode of Tails From the Lab, hosts Drs. Holly Brown and Brad Ryan talk through a case study of Clementine, a nine-year-old indoor cat who came in for a routine wellness visit appearing perfectly healthy. Her owner was hesitant about the need for extensive diagnostics, but the decision to proceed uncovered a silent but significant health issue: hypercalcemia. From exploring differential diagnoses like neoplasia and hyperparathyroidism to utilizing specialist consultations for imaging and nutrition, this case is a perfect illustration of how early detection leads to early intervention. Discover how a simple blood test created an opportunity to protect Clementine's long-term health and why "normal" results are just as valuable as abnormal ones. Tails From the Lab is a production of Antech Diagnostics™. The intent of this podcast is to provide education and guidance with the understanding that any diagnostic testing and treatment decisions are ultimately at the discretion of the attending veterinarian within the established veterinarian-patient-client relationship.

What if most heart attacks could be predicted—and prevented—years before symptoms appear? In this episode, Dr. John Osborne, Harvard-trained cardiologist and Co-Founder of ClearCardio, explains how advanced imaging, AI-powered diagnostics, and preventive cardiology are reshaping the future of heart health. With decades of experience in cardiovascular medicine, Dr. Osborne focuses on identifying hidden cardiac risk before catastrophic events occur. His work combines cutting-edge technology with a proactive approach to detecting plaque, assessing vascular health, and helping patients understand the real drivers of heart disease. In this conversation, we explore: ·       What actually causes heart attacks and sudden cardiac death. ·       The difference between soft plaque and calcified plaque in coronary artery disease. ·       Why "normal" stress tests can still miss dangerous cardiovascular risk. ·       How AI-powered cardiac imaging is improving early detection and prevention. ·       The limitations of stents and why prevention matters more than intervention. From metabolic health and inflammation to precision imaging and longevity, this episode offers a modern perspective on protecting cardiovascular health before problems arise. To learn more about Dr. John Osborne and ClearCardio, connect with him on LinkedIn. Episode also available on Apple Podcasts: https://apple.co/38oMlMr 

On this episode of Marni On The Move,Marni sits down with Sean Hoess, founder and CEO of Eudēmonia Summit, the immersive wellness gathering bringing together leading brands, practitioners, innovators, thought leaders, and consumers across wellness, longevity, recovery, mindfulness, movement, and preventative health. We dive inside the rapidly evolving wellness and longevity movement shaping the future of human optimization — from peptides and NAD+ to advanced diagnostics, preventative health screenings, recovery technologies, mindfulness, and performance. You may also know Sean as one of the original founders behind Wanderlust Festival, one of the pioneering platforms that helped shape modern wellness culture. In this conversation, Shaun shares where the idea for Eudēmonia began, the meaning behind the Greek concept of “eudaimonia” — often translated as human flourishing or a life well lived — and how he's been building Eudēmonia into a platform and experiential event where people can come discover emerging wellness trends, technologies, brands, ideas, and conversations shaping the future of longevity and human optimization. We also talk about the evolution of wellness culture, the growing demand for immersive wellness experiences, and why community, connection, and discovery are becoming central to the future of the wellness industry. Topics include: The vision behind Eudēmonia Summit Building an immersive wellness and longevity platform The growth of experiential wellness events Wellness trends shaping the future of longevity Mindfulness, movement & modern wellness culture Why community and connection matter more than ever Listen now on Marni On The Move. CONNECT Eudemonia on Instagram. Marni On The Move Instagram, TikTok, LinkedIn, or YouTube` Marni Salup on Instagram and Playlist on Spotify SUBSCRIBE TO OUR NEWSLETTER Sign up for our monthly newsletter, Do What Moves You, for Marni on the Move updates, exclusive offers, invites to events, and exciting news! SUPPORT THE PODCAST Leave us a five stars and a review on Apple, it’s easy, scroll through the episode list on your podcast app, click on five stars, click on leave a review, and share what you love about the conversations you’re listening to. Tell your friends the episodes you are listening to on your social. Share a screen shot of the episode in your stories, tag us, we will tag you back!

John talks with Dr. Peter Michalos about how artificial intelligence and remote monitoring are transforming healthcare. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Prather says that "100% of women" need help in balancing their hormones based on the lab tests he sees in patients.  In this episode, you'll learn:—How women have 64 different Hormones to consider when trying to balance them, while men basically have to worry about 2.  And why Dr. Prather says that balancing a woman's hormones is like trying to target "a jackrabbit jumping all over the place".—Why Dr. Prather says that every woman should think about being on some sort of supplementation to help balance her hormones.—The symptoms of hormonal imbalance, including: hot flashes, mood changes, cramps, irregular periods, immune system issues, heart palpitations, and even digestion problems. —The risks of pharmaceutical hormones, which only 2% of women should actually be taking according to research.  And why bioidentical hormones are NOT natural, even though some women taking them think they are.—The role of "food grade" Herbals, Glandulars, and Homeopathics in helping the body to regulate your hormones naturally and without the risk of side effects.  And how Holistic Integration can actually test to see which ones will work best for you.—Why Dr. Prather says that you are not going to balance the hormones if your Copper/Zinc ratio is not balanced.  And how Breast Cancer and Ovarian Cancer "increase quite dramatically" when a woman has too high Copper levels.—How balancing your hormones can often balance your Cholesterol.  And how getting your Cholesterol too low (under 140) will interfere with the balance of your hormones. —Why Iodine "is absolutely critical for females."  And how women who take Thyroid medication have "a very large jump in your chances of having Breast Cancer" and low Iodine is "the leading cause of Breast Cancer".—Why Dr. Prather says that, if your Liver is not working right, "you will never get your Hormones completely balanced".  And how the Adrenals can make every single hormone in the body, but are low-functioning in almost everyone.—The Diagnostics you should have to diagnose the state of your Hormone Health.  And why Chiropractic & Acupuncture are important for balancing out your Hormones and causing "almost immediate" changes.http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In a rapidly evolving industry landscape, artificial intelligence has emerged as a game-changer, transforming how major pharmaceutical companies approach drug development and diagnostics. Roche's strategic acquisition of PathAI for over $1 billion exemplifies this shift, highlighting the growing importance of AI-driven diagnostics in digital pathology. This move signals a broader trend where AI is no longer just a theoretical concept but a practical tool enhancing healthcare delivery. Alnylam's recent challenges with its web-based presentation of Amvuttra data underscore the need for accuracy in representing clinical data digitally—showing that while AI can offer innovative ways to present data, it also demands rigorous standards to ensure clarity and prevent misleading claims. On the regulatory front, the FDA's evolving stance on cell therapy Ebvallo, alongside its new one-day assessment pilot program, is shaping the industry's regulatory environment. The reconsideration of Ebvallo's earlier rejection due to single-arm trial data concerns illustrates the FDA's willingness to adapt its regulatory framework to accommodate innovative therapies. This adjustment could potentially pave the way for other gene therapies in development, including those by UniQure. Moreover, Sanofi's withdrawal of Tzield from the FDA's contentious Commissioner's National Priority Voucher program reflects ongoing debates about expedited review processes, underscoring the need for transparent and efficient pathways for bringing new therapies to patients swiftly. Additionally, the FDA's AI-guided inspection pilot aims to modernize compliance strategies and enhance pharmaceutical manufacturing oversight. In clinical trials, companies continue to face both triumphs and setbacks. Entrada Therapeutics experienced a significant decline in stock value following underwhelming Duchenne Muscular Dystrophy trial results, potentially reshaping competitive dynamics in favor of rivals like Novartis. Conversely, Angelini Pharma is making strategic moves with its $4.1 billion acquisition of Catalyst Pharmaceuticals, targeting market expansion in the U.S. through Firdapse, which is poised to make significant impacts in treating rare diseases. MingMed Biotechnology's promising phase 2 results for QA102 could signal new treatment paradigms for dry AMD—a condition with limited current interventions. Therapeutic innovation is also being driven by policy shifts that encourage research into psychedelic drugs for mental health treatment. Optimi Health's IPO indicates growing investor interest in this area, fueled by regulatory easing under recent executive orders aimed at facilitating psychedelic research. Strategic pipeline adjustments are evident as companies realign their focus based on emerging data insights. Ascendis Pharma's decision to halt its IL-2 oncology program marks a shift toward more promising avenues, while Beone Medicines' restructuring reflects a similar strategy by discontinuing several early-stage cancer programs. The industry's dynamism is further illustrated by Eli Lilly's substantial $4.5 billion investment in expanding its Indiana campus. This move not only enhances Lilly's capacity for genetic medicine and metabolic disease manufacturing but also underscores a broader industry commitment to precision medicine and biologics—fields anticipated to play pivotal roles in future healthcare solutions. Meanwhile, Bayer's acquisition of Perfuse Therapeutics seeks to bolster its ophthalmology portfolio, addressing significant unmet needs in eye disease treatments. Novo Nordisk's success with Wegovy highlights strong market demand for effective obesity treatments, demonstrating an industry-wide shift towards addressing lifestyle-related diseases. LegislSupport the show

Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) and Novo Nordisk (NVO), advances in diagnostics from Natera (NTRA), and continued strength in med tech leaders like Intuitive Surgical (ISRG) and Edwards Lifesciences (EW) as key areas of expansion.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Why is brain cancer so hard to detect and treat - and what if we could change that? In this episode of Rx for Biotech, host Chris Leidli sits down with Marc Hedrick, CEO of Plus Therapeutics, and Russell Bradley, General Manager of CNSide Diagnostics, to explore a new, integrated approach to treating some of the most challenging cancers in medicine: central nervous system (CNS) cancers, including glioblastoma and leptomeningeal metastases. Brain and CNS cancers are among the most difficult to treat because of the blood-brain barrier, which prevents most drugs from reaching tumors. In fact, only a small percentage of therapies can effectively cross into the brain—limiting treatment options and outcomes. Plus Therapeutics is tackling this problem with a novel approach using targeted radiation therapy delivered directly to tumors, bypassing the blood-brain barrier. Their lead program uses a radioactive isotope (rhenium-186) delivered via nanoliposomes, allowing high doses of radiation to reach the tumor while minimizing damage to the rest of the body. At the same time, CNSide Diagnostics is helping physicians detect cancer earlier and monitor treatment response using an advanced cerebrospinal fluid (CSF) diagnostic test. This highly sensitive test can identify even small numbers of tumor cells—helping doctors make faster, more informed treatment decisions. Together, this combination of diagnostics + therapeutics + data represents a new model for precision oncology and personalized cancer care. In this episode, we discuss: • Why brain cancer is so difficult to treat • The role of the blood-brain barrier in limiting therapies • How targeted radiation therapy can improve outcomes • The importance of early detection and diagnostics • How monitoring tumor cells can guide treatment decisions • The future of integrated cancer care (theranostics) This conversation offers a powerful look at how innovation in both treatment and diagnostics could help improve survival and quality of life for patients with some of the most aggressive cancers.

In this episode, Mirianas Chachisvilis, Ph.D., CEO & CTO, Veriskin, Inc., discusses building and scaling a medical device company, navigating clinical trials and FDA pathways, and creating a cost effective model to improve early skin cancer detection and reduce unnecessary healthcare spending.

What really happens after you send a plant sample to the lab, and how does it impact what happens back in the field? In this episode of Outstanding in Your Field, the team sits down with Corteva Plant Pathology Technology Lead Krystel Navarro to pull back the curtain on the diagnostic lab and the critical role it plays in modern agriculture. From identifying crop diseases with molecular precision to supporting product development and protecting yields, this conversation explores how science, speed, and field expertise come together to solve real-world challenges. Krystal shares her journey from hydroponic farming roots in Puerto Rico to leading a cutting-edge pathology lab. She explains how advanced diagnostics help distinguish between lookalike diseases, guide management decisions, and even shape the future of seed development. The discussion also dives into real-world examples—like tracking emerging corn diseases—and highlights how collaboration between labs, agronomists, and farmers leads to better outcomes across the industry. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Mirianas Chachisvilis, Ph.D., CEO & CTO, Veriskin, Inc., discusses building and scaling a medical device company, navigating clinical trials and FDA pathways, and creating a cost effective model to improve early skin cancer detection and reduce unnecessary healthcare spending.

Despite Microsoft's promises, real Windows 11 annoyances like forced telemetry, aggressive Edge defaults, and stubborn online account requirements remain unaddressed. Paul Thurrott calls out what isn't changing and why power users should care. Host: Paul Thurrott Download or subscribe to Hands-On Windows at https://twit.tv/shows/hands-on-windows Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Club TWiT members can discuss this episode and leave feedback in the Club TWiT Discord.

Despite Microsoft's promises, real Windows 11 annoyances like forced telemetry, aggressive Edge defaults, and stubborn online account requirements remain unaddressed. Paul Thurrott calls out what isn't changing and why power users should care. Host: Paul Thurrott Download or subscribe to Hands-On Windows at https://twit.tv/shows/hands-on-windows Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Club TWiT members can discuss this episode and leave feedback in the Club TWiT Discord.

Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, highlights the critical role of advanced precision diagnostics and how these tools are driving true precision medicine, where therapies are targeted to specific genetic mutations. There have been significant innovations, such as less invasive liquid biopsies and the application of AI to interpret medical images and complex lab results, which provide faster analysis and make it easier to monitor disease over time. The future of diagnostics includes more routine tests and imaging to enable earlier interventions and more effective treatments by overcoming the logistical and physical challenges of traditional tissue biopsies in cancer care. Bill explains, "At Avalon, we believe that if you don't get the diagnosis right, the rest of healthcare is wasted, and time is wasted on getting a patient better. So our number one focus is getting the science of diagnostics deployed into the healthcare ecosystem. I think a lot of people know that there's been a lot of innovation in lab testing, as well as in advanced diagnostic imaging. And historically, it takes 17 to 20 years to get new science evenly adopted, and we want to accelerate that process. So that's really our focus. We say sciences are True North, and our goal is to get that science deployed into the healthcare system."   "I think, unfortunately, we used the phrase precision medicine too early. When it was really precision diagnostics, and I'll separate the two out. For over a decade, we've been able to measure, let's say for instance, in cancer, what mutations might be in the cancer cells, but we didn't have any new therapies to offer. So while the phrase precision medicine was used, all we did was identify the mutations, build up an understanding of the disease, but offer the same cancer therapy. Now we actually have therapies that target some of those specific mutations."   "We truly have reached the era of precision medicine. But I think getting people to understand that now it's not just measuring the mutation, it's measuring the mutation and selecting the chemotherapy based on that. That's the new reality, and that's what we're trying to get people to understand. And that's why I think undertesting still happens, because people aren't maybe aware that now there are therapeutic decisions you can make off those results." #Avalonhcs #PrecisionMedicine #Diagnostics #HealthcareInnovation #LiquidBiopsy #Healthtech #DiagnosticIntelligence  #AIinHealthcare #PersonalizedMedicine #Oncology #HealthcareProfessionals #MedicalTechnology #PatientCare avalonhcs.com Download the transcript here

Dr. Bill Kerr, Co-Founder and CEO of Avalon Healthcare Solutions, highlights the critical role of advanced precision diagnostics and how these tools are driving true precision medicine, where therapies are targeted to specific genetic mutations. There have been significant innovations, such as less invasive liquid biopsies and the application of AI to interpret medical images and complex lab results, which provide faster analysis and make it easier to monitor disease over time. The future of diagnostics includes more routine tests and imaging to enable earlier interventions and more effective treatments by overcoming the logistical and physical challenges of traditional tissue biopsies in cancer care. Bill explains, "At Avalon, we believe that if you don't get the diagnosis right, the rest of healthcare is wasted, and time is wasted on getting a patient better. So our number one focus is getting the science of diagnostics deployed into the healthcare ecosystem. I think a lot of people know that there's been a lot of innovation in lab testing, as well as in advanced diagnostic imaging. And historically, it takes 17 to 20 years to get new science evenly adopted, and we want to accelerate that process. So that's really our focus. We say sciences are True North, and our goal is to get that science deployed into the healthcare system."   "I think, unfortunately, we used the phrase precision medicine too early. When it was really precision diagnostics, and I'll separate the two out. For over a decade, we've been able to measure, let's say for instance, in cancer, what mutations might be in the cancer cells, but we didn't have any new therapies to offer. So while the phrase precision medicine was used, all we did was identify the mutations, build up an understanding of the disease, but offer the same cancer therapy. Now we actually have therapies that target some of those specific mutations."   "We truly have reached the era of precision medicine. But I think getting people to understand that now it's not just measuring the mutation, it's measuring the mutation and selecting the chemotherapy based on that. That's the new reality, and that's what we're trying to get people to understand. And that's why I think undertesting still happens, because people aren't maybe aware that now there are therapeutic decisions you can make off those results." #Avalonhcs #PrecisionMedicine #Diagnostics #HealthcareInnovation #LiquidBiopsy #Healthtech #DiagnosticIntelligence  #AIinHealthcare #PersonalizedMedicine #Oncology #HealthcareProfessionals #MedicalTechnology #PatientCare avalonhcs.com  Listen to the podcast here

Do you know how to apply best practices for HER2 testing and identify patients who may benefit from targeted therapies? Join us to learn more! Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-care-her2-mutated-nsclc-evidence-diagnostics-and-2026a1000d6g?ecd=bdc_podcast_libsyn_mscpedu

Thanks to our Partners, NAPA Auto Care and NAPA TRACS Watch Full Video Episode Recorded live at the TST Big Event 2026, host Carm Capriotto sits down with Andrew Fischer, shop manager at Cergizan's Auto and Truck Repair in Northwest Indiana, and an industry trainer. Andrew shares his disciplined, process-driven approach to diagnostics, his passion for technician development, and why shop culture plays a defining role in long-term success. From daily habits to big-picture philosophy, this conversation is a roadmap for building more confident, capable technicians. What You'll Learn: Why committing to at least 40 hours of continuous education each year can dramatically reduce comebacks and improve shop performanceHow to build learning into daily routines: whether through short practice sessions, webinars, or online training resourcesThe power of Standard Operating Procedures (SOPs) and why “going rogue” in diagnostics leads to inefficiencyHow Andrew's “detective mind mapping” technique helps technicians visually organize problems and accelerate accurate diagnosesWhy revisiting foundational knowledge is critical and how ego often prevents technicians from mastering the basicsHow embracing failure strengthens diagnostic ability and builds real-world expertiseThe importance of capturing and studying “known good” vehicle data to improve accuracy on future repairs Great diagnostics is about discipline, process, and constant learning. Shops that invest in their people, reinforce foundational skills, and create a culture where failure fuels growth will not only solve problems faster but build stronger, more resilient teams. TST Big Event: https://tstseminars.org/ Andrew Fischer, Cergizan's Auto and Truck Repair, Burns Harbor, IN. Fischer Automotive Consulting and Training Services: factsautomotive@gmail.com Thanks to our Partners, NAPA Auto Care and NAPA TRACS Learn more about NAPA Auto Care and the benefits of being part of the NAPA family by visiting https://www.napaonline.com/en/auto-care NAPA TRACS will move your shop into the SMS fast lane with onsite training and six days a week of support and local representation. Find NAPA TRACS on the Web at http://napatracs.com/ Connect with the Podcast: Visit the Website:https://remarkableresults.biz/Subscribe on YouTube:https://www.youtube.com/carmcapriottoFollow on Facebook:https://www.facebook.com/RemarkableResultsRadioPodcast/Follow on LinkedIn:https://www.linkedin.com/in/carmcapriotto/Follow on Instagram:https://www.instagram.com/remarkableresultsradiopodcast/Join Our Virtual Toastmasters Club:https://remarkableresults.biz/toastmastersJoin Our Private Facebook Community:https://www.facebook.com/groups/1734687266778976Join our Insider List:https://remarkableresults.biz/insiderAll books mentioned on our podcasts:https://remarkableresults.biz/booksOur Classroom page for personal or team learning:https://remarkableresults.biz/classroomBuy Me a Coffee:https://www.buymeacoffee.com/carmSpecial episode collections:https://remarkableresults.biz/collections The Automotive Repair Podcast Network: https://automotiverepairpodcastnetwork.com/ Remarkable Results Radio Podcastwith Carm Capriotto: Advancing the Aftermarket by Facilitating Wisdom Through Story Telling and Open Discussion.https://remarkableresults.biz/Diagnosing the Aftermarket A to Zwith Matt Fanslow: From Diagnostics to Metallica and Mental Health, Matt Fanslow is Lifting the Hood on Life.https://mattfanslow.captivate.fm/Business by the Numberswith Hunt Demarest: Understand the Numbers of Your Business with CPA Hunt Demarest.https://huntdemarest.captivate.fm/The Auto Repair Marketing Podcastwith Kim and Brian Walker: Marketing Experts Brian & Kim Walker Work with Shop Owners to Take it to the Next Level.https://autorepairmarketing.captivate.fm/The Weekly Blitzwith Chris Cotton: Weekly Inspiration with Business Coach Chris Cotton from AutoFix - Auto Shop Coaching.https://chriscotton.captivate.fm/Speak Up! Effective Communicationwith Craig O'Neill: Develop Interpersonal and Professional Communication Skills when Speaking to Audiences of Any Size.https://craigoneill.captivate.fm

In this episode of the HVAC Know It All Podcast, host Gary McCreadie talks with Eric Ruggles, Director of Engineering at Ritchie Engineering Co., Inc. (YELLOW JACKET), about airflow, static pressure, and modern diagnostic tools. In Part 2, they discuss proper system commissioning, checking pressure across components, and identifying airflow restrictions without disassembling equipment. Eric explains how tools like a digital manometer and wireless probes help measure system performance, airflow, and gas pressure. They also cover the shift from manifolds to probes, including concerns about refrigerant loss and system contamination. The conversation wraps up with practical insights on using airflow, temperature, and CFM measurements to determine true system capacity and improve service decisions. Gary and Eric discuss airflow testing, static pressure, and how modern tools improve system diagnostics and performance. They explain how proper commissioning sets baseline readings and helps identify issues like plugged coils or airflow restrictions. Eric describes how digital manometers and probes can measure pressure, airflow, and gas pressure while creating reports for customers. They also cover the shift from manifolds to probes, including concerns about refrigerant loss and contamination. They finish by explaining how airflow, temperature, and CFM measurements can confirm true system capacity and support better service decisions. Expect to Learn: How proper commissioning helps set baseline readings for system performance. How checking static pressure across components can reveal airflow restrictions. Why tools like digital manometers and probes improve accuracy in diagnostics. How wireless probes can measure pressure, airflow, and gas without losing refrigerant. How airflow, temperature, and CFM readings help confirm true system capacity.   Episode Highlights: [00:00] - Sponsor: Factory Direct Filters ad [00:42] - Intro to Eric Ruggles in Part 02  [02:03] - Checking static across devices [03:58] - Yellow Jacket Mano tool overview [05:32] - Probes vs. manifolds debate [12:08] - Calculate real BTU capacity without gauges [15:32] - 3-tool non-invasive maintenance [16:55] - Duct traverse with Y Jack Flow   This Episode is Kindly Sponsored by: Cintas: https://www.cintas.com/hvacknowitall Cool Air Products: https://www.coolairproducts.net/ Factory Direct Filters: https://www.factorydirectfilters.com/ SupplyHouse: https://www.supplyhouse.com/tm Use promo code HKIA5 to get 5% off your first order at Supplyhouse!   Follow the Guest Eric Ruggles on:  LinkedIn: https://www.linkedin.com/in/eric-ruggles-28a84424/   Ritchie Engineering Co., Inc. (YELLOW JACKET): https://www.linkedin.com/company/ritchie-engineering-co-yellow-jacket-/   Ritchie Engineering Co., Inc. (YELLOW JACKET) - Website: https://yellowjacket.com/    Follow the Host on: LinkedIn: https://www.linkedin.com/in/gary-mccreadie-38217a77/  Website: https://www.hvacknowitall.com Facebook: https://www.facebook.com/people/HVAC-Know-It-All-2/61569643061429/   Instagram: https://www.instagram.com/hvacknowitall1/  Follow the Podcast on:  YouTube: https://www.youtube.com/@HVACKnowItAll   Spotify: https://open.spotify.com/show/6LCBJGw0EHG03rdWHxUMce  Apple Podcast: https://podcasts.apple.com/us/podcast/hvac-know-it-all-podcast/id1359253455 

Danny Abraham, CEO & Founder of Orca Dental AI & CephX joins the show and discusses: AI revolutionizing ortho diagnostics & workflow AI will become standard of care in orthodontics ROI from efficiency, outcomes & legal protection To learn more about CephX visit: https://cephx.com/ To contact Danny you can email him here: danny@cephx.com      

This episode recorded live at the Becker's 16th Annual Meeting features Dr. Stephen Master, MD, PhD, Vice Chair for Innovation, Department of Pathology and Laboratory Medicine, Director, CHOP Center for Diagnostic Innovation, CHOP, Dr. Deborah Boles, PhD, Vice President, Research & Development, Labcorp, & Dr. Mindy Nye, PhD, MT (ASCP), D (ABMM), Vice President, Labcorp Diagnostics, Labcorp, who discuss how collaboration is accelerating diagnostic innovation and expanding access to pediatric care. They explore how shared infrastructure, aligned missions, and co-development models enable scalable, high-impact solutions for patients.This episode is sponsored by Labcorp.

Michael Jewett is a pioneer of cell-free biotechnology. Instead of using living microbes as factories, he uses their internal molecular machinery to make valuable proteins, medicines, diagnostics, and other chemicals. Jewett recently used the technique for vaccine production in an approach that could produce up to 150,000 doses from one liter. He believes cell-free biotech could democratize the production of essential medicines, improve water safety, and help convert atmospheric carbon into useful products, among other promising possibilities. “It's just-add-water biotechnology,” Jewett tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Michael Christopher Jewett Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces Mike Jewett, a professor of bioengineering and chemical engineering at Stanford University. (00:03:23) What Is Cell-Free Biotechnology? Using the internal machinery of cells without the cells themselves. (00:04:20) Removing “Evolutionary Baggage” Why cells' natural priorities can conflict with engineering goals. (00:07:41) Advantages of Cell-Free Systems From large-scale production to decentralized, on-demand manufacturing. (00:11:40) Making Proteins Outside Cells How DNA instructions are used to produce functional proteins. (00:13:49) Biosensors for Water Safety Detecting contaminants like lead using engineered proteins. (00:17:05) Engineering Better Sensors Improving sensitivity and selectivity through protein design. (00:20:33) AI in Bioengineering How data and models accelerate discovery and design. (00:23:22) Sustainability & Carbon Capture Turning atmospheric carbon into useful chemicals. (00:26:18) Building New Biological Pathways Combining chemistry and biology to create novel production systems. (00:27:54) From Molecules to Materials How acetyl-CoA enables fuels, plastics, and other products. (00:30:51) Teaching Biotechnology Making biotech accessible through hands-on, “just-add-water” kits. (00:33:12) Future In a Minute Rapid-fire Q&A: innovation, collaboration, and the future of biotech. (00:35:32) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us Fan MailIf you or someone you love just received a cancer diagnosis, what are the first three things you need to know?In this clip from our episode “Can AI Help Us Finally Beat Cancer”, host John Driscoll and guest Dr. Sanjay Juneja, TheOncDoc, walk through the essential steps every cancer patient should take immediately after diagnosis.Listen to the full episode here

We are in week three of a four-part series on the 4th-largest killer in America.  This week, we talk about how Holistic Integration is able to know exactly why a patient has Hypertension—and how to fix it—after running the proper diagnostics.  In this episode, you'll find out:—How men are 20% more likely to have a Stroke, but Women are 40% more likely to die from a Stroke.—Why it is more dangerous for "the bottom number" of your Blood Pressure (Diastolic) to be high than "the top number" (Systolic).—The surprising meaning of the diagnosis "essential" or primary Hypertension, which is 90-95% of all the Hypertension diagnosed.   And how Dr. Prather has found that 70% of all Hypertension cases actually are because of low Kidney function.—The importance of knowing your GFR (Glomerular Filtration Rate), which measures how well your Kidneys are working.—Why it's considered "unusual" for Kidney function to be improved, but Holistic Integration has been able to prove is possible"time and time again".—What is revealed by the ANS (Autonomic Nervous System) Test that is done for all new patients at Holistic Integration.   And how the ANS Test is "the Gold Standard" test for measuring Nitric Oxide, which is an important factor in Hypertension. —Why the Cardiac C-Reactive Test is "probably the most important test for Stroke besides Blood Pressure".—How you are 10 times more likely to have a Stroke if you have had a TIA (transient ischemic attack) in the previous year. —The importance of the proper balance between the Parasympathetic and Sympathetic systems for reducing your chances of a Stroke.  And how the Atlas Orthogonal Chiropractic Adjustment is able to help Hypertension cases where the root cause is a Vagus Nerve issue. —How a Hair Analysis reveals the imbalances of your body's Mineral levels, which increase your risk of a Stroke.http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

Andrea Prinzi, Ph.D., MPH, SM(ASCP), and Rodney Rohde, Ph.D.,SM(ASCP)CM, SVCM, trace how passion‑driven, nonlinear paths in clinical microbiology led them from hospital benches and public health labs to academia and industry leadership. Their stories converge on a shared mission: to use diagnostics, outcomes research and lived experience to make microbiology relevant, contextual and approachable for patients, policymakers and the broader public. Links for This Episode: View Prinzi's ASM articles.  View Rohde's ASM articles. Volunteer to write for ASM. Take the MTM listener survey!

Don't get to the end of this year wishing you had taken action to change your business and your life.Click here to schedule a free discovery call for your business: https://geni.us/IFORABEShop-Ware gives you the tools to provide your shop with everything needed to become optimally profitable.Click here to schedule a free demo: https://info.shop-ware.com/profitabilityUtilize the fastest and easiest way to look up and order parts and tires with PartsTech absolutely free.Click here to get started: https://geni.us/PartsTechTransform your shop's marketing with the best in the automotive industry, Shop Marketing Pros! Get a free audit of your shop's current marketing by clicking here: https://geni.us/ShopMarketingPros In this episode, Lucas Underwood and David Roman are joined by Ira Waldman and Tim Iezzi, who share their experiences with technical training and diagnostics in the automotive industry. Ira Waldman explains the value of comprehensive accident investigations and how data pulled from vehicles is increasingly crucial for liability and repairs. Tim Iezzi and Ira Waldman detail their hands-on training classes, emphasizing the importance of practicing with equipment to build real skills. Throughout the conversation, the group discusses challenges facing trainers—including undervaluation and barriers to fair compensation—while reflecting on what true success looks like in the industry.00:00 Consulting work and accident investigations04:58 Calibration data and liability concerns08:48 Lab scope training launch11:32 Practicing lab scope basics15:25 Common mistakes using scopes19:03 Importance of planning and tools20:10 Teaching procedural oil change steps24:46 Improving technician education27:00 Training value and budget changes32:48 Challenges faced by fitness trainers36:16 Launching the training company39:46 Impact of low-cost car markets41:29 Covid's impact on auto repairs47:30 Troubleshooting equipment issues50:25 Defining personal success52:21 Interviewing successful people54:28 Thanking the audience